{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T23:52:08Z","timestamp":1793490728421,"version":"4.5.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:00:00Z","timestamp":1707436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Anemia remains a prevalent global health issue with varying severity. Intravenous iron supplementation, particularly with ferric carboxymaltose (FCM), has appeared as a possible therapeutic intervention for individuals with moderate to severe anemia. The study aimed to assess the efficacy and safety of ferric carboxymaltose (FCM) in reducing anemia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We searched electronic databases, registries, websites, e-libraries, reference lists of reviews, citations, etc. We included randomized control trials (RCTs), non-RCTs, and single-arm studies, while observational studies, case series, and case studies were excluded. Two reviewers independently screened the studies and extracted the data. We included studies of moderate-to-severely anemic Indians and excluded Indians with other comorbidities. We assessed the risk of bias and the overall quality of evidence (QoE) using GRADE GDT.<\/jats:p><\/jats:sec><jats:sec><jats:title>Result<\/jats:title><jats:p>We identified 255 studies and included 14 studies (11 RCT, one non-RCT, and two single-arm studies) with 1,972 participants for qualitative analysis and 10 studies in the meta-analysis. All the included studies detailed the use of FCM for anemia. The primary outcomes assessed in the included studies were anemia, hemoglobin, and adverse events. The outcomes assessed ranged from 2\u2009weeks to 12\u2009weeks. The risk of bias varied across different studies with different outcomes. FCM is consistent with a fewer number of adverse events as compared to other interventions and provides \u201cmoderate\u201d to \u201cvery low\u201d QoE.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>A slow single infusion of 1\u2009gram of FCM is well-tolerated, safe, and effective in treating iron deficiency anemia (IDA) and surpasses other interventions (Iron Sucrose Complex (ISC), Iron sucrose, and ferrous ascorbate) in elevating hemoglobin levels and replenishing iron stores.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic Review Registration<\/jats:title><jats:p><jats:ext-link>https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?RecordID=459363<\/jats:ext-link>, CRD42023459363.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2024.1340158","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T04:48:07Z","timestamp":1707454087000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of IV ferric carboxy maltose for moderate\/severe anemia: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"11","author":[{"given":"Mahalaqua Nazli","family":"Khatib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anju Pradhan","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa","family":"Gaidhane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa","family":"Upadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Waghmare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Anil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailendra","family":"Sawleshwarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padam Prasad","family":"Simkhada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhay","family":"Gaidhane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahiruddin Syed","family":"Quazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,9]]},"reference":[{"key":"ref1","year":""},{"key":"ref2","year":"2013"},{"key":"ref3","year":"2022"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/5759740","article-title":"Ferric Carboxymaltose in the Management of Iron Deficiency Anemia in pregnancy: a subgroup analysis of a Multicenter real-world study involving 1191 pregnant women","volume":"2022","author":"Trivedi","year":"2022","journal-title":"Obstet Gynecol Int"},{"key":"ref5","volume-title":"Worldwide prevalence of anemia 1993\u20132005: WHO global database on anemia","year":"2008"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"146","DOI":"10.15537\/smj.2015.2.10289","article-title":"The impact of maternal iron deficiency and iron deficiency anemia on child\u2019s health","volume":"36","author":"Abu-Ouf","year":"2015","journal-title":"Saudi Med J"},{"key":"ref7","first-page":"283","article-title":"Iron deficiency in pregnancy and the rationality of iron supplements prescribed during pregnancy","volume":"10","author":"Gautam","year":"2008","journal-title":"Medscape J Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.18203\/2320-1770.ijrcog20202325","article-title":"A comparative study of ferric carboxymaltose and iron sucrose as a parenteral iron treatment in iron deficiency anemia during pregnancy","volume":"9","author":"Patel","year":"2020","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1280S","DOI":"10.1093\/ajcn\/71.5.1280s","article-title":"Anemia and iron deficiency: effects on pregnancy outcome","volume":"71","author":"Allen","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1016\/S2214-109X(20)30448-4","article-title":"Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron deficiency anemia in women after childbirth in Tanzania: a parallel-group, open-label, randomized controlled phase 3 trial","volume":"9","author":"Vanobberghen","year":"2021","journal-title":"Lancet Glob Health"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2147\/JBM.S361210","article-title":"Efficacy and safety of ferric Carboxymaltose in the Management of Iron Deficiency Anemia: a multi-Center real-world study from India","volume":"13","author":"Charmila","year":"2022","journal-title":"J Blood Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/1471-2393-14-115","article-title":"Intravenous ferric carboxymaltose for anemia in pregnancy","volume":"14","author":"Froessler","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"739","DOI":"10.2165\/00003495-200969060-00007","article-title":"Ferric Carboxymaltose: a review of its use in iron-deficiency anemia","volume":"69","author":"Lyseng-Williamson","year":"2009","journal-title":"Drugs"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.18203\/2320-1770.ijrcog20192418","article-title":"A study for efficacy and safety of ferric carboxymaltose versus iron sucrose in iron deficiency anemia among pregnant women in tertiary care hospital","volume":"8","author":"Agrawal","year":"2019","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12884-019-2200-3","article-title":"Comparison of ferric Carboxymaltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy-randomized controlled trial","volume":"19","author":"Jose","year":"2019","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"324","DOI":"10.4103\/0970-258X.321145","article-title":"Intravenous ferric carboxymaltose rapidly increases hemoglobin and serum ferritin among pregnant females with moderate-to-severe anemia: a single-arm, open-label trial","volume":"33","author":"Kant","year":"2020","journal-title":"Natl Med J India"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"nzab078","DOI":"10.1093\/cdn\/nzab078","article-title":"Single dose of intravenous ferric Carboxymaltose prevents Anemia for 6 months among moderately or severely Anemic postpartum women: a case study from India","volume":"5","author":"Kaur","year":"2021","journal-title":"Curr Dev Nutr"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"505","DOI":"10.18203\/2320-1770.ijrcog20220179","article-title":"Comparative study of intravenous iron sucrose versus intravenous ferric carboxymaltose in the management of iron deficiency anemia in pregnancy","volume":"11","author":"Khatun","year":"2022","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12905-017-0506-8","article-title":"Effectiveness and safety of ferric carboxymaltose compared to iron sucrose in women with iron deficiency anemia: phase IV clinical trials","volume":"18","author":"Naqash","year":"2018","journal-title":"BMC Womens Health"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.18231\/j.ijogr.2022.003","article-title":"Intravenous ferric carboxymaltose versus iron sucrose in iron deficiency anemia of pregnancy","volume":"9","author":"Parikh","year":"2022","journal-title":"IJOGR"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.18203\/2320-1770.ijrcog20222464","article-title":"Comparative efficacy and safety of ferric carboxymaltose, iron sucrose and iron sorbitol in treatment of iron deficiency anemia in Indian pregnant women","volume":"11","author":"Patil","year":"2022","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"ref22","doi-asserted-by":"crossref","DOI":"10.1002\/9781119536604","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2019"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomized trials","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomized studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"ref26","author":"Sch\u00fcnemann","year":"2013"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ijgo.2015.09.007","article-title":"Randomized controlled trial comparing ferric carboxymaltose and iron sucrose for treatment of iron deficiency anemia due to abnormal uterine bleeding","volume":"133","author":"Mahey","year":"2016","journal-title":"Int J Gynaecol Obstet"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4103\/2229-516X.149230","article-title":"Ferric carboxymaltose: a revolution in the treatment of postpartum anemia in Indian women","volume":"5","author":"Rathod","year":"2015","journal-title":"Int J Appl Basic Med Res"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"100","DOI":"10.18203\/2320-1770.ijrcog20215083","article-title":"Comparative study of efficacy and safety of parenteral iron sucrose versus ferric carboxymaltose in treatment of postpartum iron deficiency anemia","volume":"11","author":"Dakhale","year":"2021","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s13224-017-0971-x","article-title":"Comparative study of efficacy and safety of ferric Carboxymaltose versus iron sucrose in post-partum anemia","volume":"67","author":"Sharma","year":"2017","journal-title":"J Obstet Gynecol India"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"QC08","DOI":"10.7860\/JCDR\/2016\/19375.8937","article-title":"IV ferric Carboxymaltose vs Oral iron in the treatment of post-partum iron deficiency anemia","volume":"10","author":"Damineni","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"ref32","author":"Higgins","year":"2022"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1055\/s-0038-1668555","article-title":"Treatment of iron deficiency Anemia in pregnancy with intravenous versus Oral iron: systematic review and meta-analysis","volume":"36","author":"Govindappagari","year":"2019","journal-title":"Am J Perinatol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/17474086.2019.1575202","article-title":"A systematic literature review and indirect comparison of iron isomaltoside and ferric carboxymaltose in iron deficiency anemia after failure or intolerance of oral iron treatment","volume":"12","author":"Pollock","year":"2019","journal-title":"Expert Rev Hematol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/ajo.12695","article-title":"Safety and efficacy of intravenous iron polymaltose, iron sucrose and ferric carboxymaltose in pregnancy: a systematic review","volume":"58","author":"Qassim","year":"2018","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s40261-015-0361-z","article-title":"Efficacy and safety of ferric Carboxymaltose and other formulations in iron-deficient patients: a systematic review and network meta-analysis of randomized controlled trials","volume":"36","author":"Rognoni","year":"2016","journal-title":"Clin Drug Investig"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e503","DOI":"10.1016\/S2352-3026(21)00137-X","article-title":"shin","volume":"8","author":"Rogozi\u0144ska","year":"2021","journal-title":"Lancet Haematol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"e24571","DOI":"10.1097\/MD.0000000000024571","article-title":"Comparative efficacy and safety of intravenous ferric carboxymaltose and iron sucrose for iron deficiency anemia in obstetric and gynecologic patients: a systematic review and meta-analysis","volume":"100","author":"Shin","year":"2021","journal-title":"Medicine (Baltimore)"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1340158\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T04:48:15Z","timestamp":1707454095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1340158\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,9]]},"references-count":38,"alternative-id":["10.3389\/fmed.2024.1340158"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1340158","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,9]]},"article-number":"1340158"}}